CS10 10mg*10vials

Cagrilintide + Semaglutide CS10 10mg*10vials

Cagrilintide + Semaglutide is a combination research peptide blend that pairs an amylin analog with a GLP-1 receptor agonist, designed for synergistic metabolic research.

The 10mg single-vial specification delivers double the active ingredient content of the standard 5mg. This formulation is ideal for long-term combination therapy studies, high-dose dual-pathway experiments, and researchers conducting extended large-animal research. The higher concentration per vial significantly reduces the number of vials needed for prolonged experiments, minimizing handling variables and operational errors from repeated dilution.

Through dual pathway activation, this blend combines GLP-1 receptor signaling with amylin pathway modulation. This supports in-depth research into appetite regulation, glycemic control, and synergistic metabolic effects that go beyond either single compound alone across extended study durations.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for long-term preclinical research and high-intensity combination therapy projects.